These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22998918)

  • 21. Endoscopic treatment with dextranomer/hyaluronic acid for persistent incontinence after continent urinary reconstruction.
    Riachy E; Defoor WR; Reddy PP; Alam S; Noh PH; Sheldon C; Minevich EA
    J Endourol; 2015 Feb; 29(2):137-40. PubMed ID: 25265053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction.
    Läckgren G; Sköldenberg E; Stenberg A
    J Urol; 2007 Mar; 177(3):1124-8; discussion 1128-9. PubMed ID: 17296428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periurethral collagen injection for the treatment of urinary incontinence in children.
    Chernoff A; Horowitz M; Combs A; Libretti D; Nitti V; Glassberg KI
    J Urol; 1997 Jun; 157(6):2303-5. PubMed ID: 9146659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Same setting laparoscopic antegrade continence enema and antegrade bladder neck injection for constipation and urinary incontinence in the spina bifida population.
    Kaye JD; Jafri SM; Cuda SP; Kalisvaart JF; Cerwinka WH; Kirsch AJ
    J Urol; 2010 Oct; 184(4 Suppl):1644-50. PubMed ID: 20728118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.
    Cerwinka WH; Qian J; Easley KA; Scherz HC; Kirsch AJ
    J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen injection for treatment of urinary incontinence in children.
    Kassouf W; Capolicchio G; Berardinucci G; Corcos J
    J Urol; 2001 May; 165(5):1666-8. PubMed ID: 11342951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
    Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC
    J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
    Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
    J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
    Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
    J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of polydimethylsiloxane in the endoscopic treatment of urinary incontinence of neurologic origin in children].
    Guys JM; Louis-Borrione C; Battagliola D; Le Hors-Albouze H; Petit P
    Ann Urol (Paris); 1999; 33(5):351-5. PubMed ID: 10544739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence in Bladder Exstrophy-epispadias Complex.
    Fiorenza V; Hukkinen M; Alova I; Clermidi P; Broch A; Botto N; Blanc T; Lottmann HB
    J Urol; 2023 Mar; 209(3):591-599. PubMed ID: 36449491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic treatment for urinary incontinence in children with a congenital neuropathic bladder.
    Silveri M; Capitanucci ML; Mosiello G; Broggi G; De Gennaro M
    Br J Urol; 1998 Nov; 82(5):694-7. PubMed ID: 9839585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcome of the Pippi Salle Procedure for Intractable Urinary Incontinence in Patients with Severe Intrinsic Urethral Sphincter Deficiency.
    Nakamura S; Hyuga T; Kawai S; Nakai H
    J Urol; 2015 Nov; 194(5):1402-6. PubMed ID: 26055826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes.
    Lightner DJ; Fox J; Klingele C
    Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.